HZNP


Biotech Beat: Analysts Bullish on Sarepta Therapeutics Inc (SRPT) and Horizon Pharma PLC (HZNP)

Analysts are bullish on both Sarepta Therapeutics Inc (NASDAQ:SRPT) and Horizon Pharma PLC (NASDAQ:HZNP) as the two biotechnology companies advance their pipelines and …

Mizuho Securities Remains Positive on Horizon Pharma PLC Following Dispute with Express Scripts

Shares of Horizon Pharma PLC (NASDAQ:HZNP) plunged nearly 20% today following a lawsuit filed by Express Scripts and recent allegations. Express Scripts cut the pharmacy Linden …

Depomed Inc’s (DEPO) Board of Directors Rejects Horizon Pharma PLC’s (HZNP) Unsolicited Exchange Offer

Depomed Inc (NASDAQ:DEPO) announced that its Board of Directors, after careful consideration and in consultation with its financial and legal advisors, has unanimously …

Company Update (NASDAQ:DEPO): Depomed Inc’s Board of Directors Unanimously Rejects Revised Proposal from Horizon Pharma PLC

Depomed Inc (NASDAQ:DEPO) announced that its Board of Directors, after careful consideration and with the assistance of its financial and legal advisors, has unanimously …

Monday Morning Pre-Market Insights: GoPro (GPRO), Yamana Gold Inc. (USA) (AUY), Exelixis, Inc. (EXEL), Horizon Pharma PLC (HZNP)

GoPro Inc (NASDAQ:GPRO) shares are up 2.40% in pre-market trading to $58.

Biotech Stock News: Oncolytics Biotech, Inc. (USA), Horizon Pharma PLC, Depomed Inc, Celgene Corporation

By Terry Chrisomalis Oncolytics Biotech, Inc. (USA) On July 6, 2015 shares of Oncolytics Biotech, Inc.

Brean Capital Raises Price Target for Horizon Pharma PLC on Back of Recent Offer to Buy Depomed

In a research report issued today, Brean Capital analyst Difei Yang reiterated a Buy rating on Horizon Pharma PLC (NASDAQ:HZNP) and raised the price …

Brean Capital Remains Positive on Horizon Pharma PLC Following 1Q Revenue Beat and Share Price Pull-Back

Brean Capital analyst Difei Yang weighed in today with her views on Horizon Pharma PLC (NASDAQ:HZNP), after the company reported its first-quarter results, posting revenue …

Brean Capital Lifts Price Target for Horizon Pharma PLC Following Acquisition of Hyperion

In a research report published Tuesday, Brean Capital analyst Difei Yang maintained a Buy rating on Horizon Pharma PLC (NASDAQ:HZNP) and raised the price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts